Deciphering the molecular basis of T1D in human cells using functional genomics
Deciphering the molecular basis of T1D in human cells using functional genomics
批准号:
9228681
负责人:
STEVEN A CARR
金额:
$416.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-30 至 2021-05-31
关键词:
AddressAffectAffinityAllelesAntigen Presentation PathwayAutoimmune DiseasesAutoimmune ProcessBeta CellBindingBinding SitesBioinformaticsBiological AssayBiologyCell physiologyCellsCellular StressChIP-seqCodeComputer SimulationDNADNA-Binding ProteinsDataData SetDiagnosticDiseaseDissectionDistalElementsEnhancersEnvironmentEnvironmental Risk FactorEtiologyFunctional disorderGene Expression RegulationGene TargetingGenesGeneticGenetic VariationGenome engineeringGenotypeGlucoseGoalsHematopoietic SystemHot SpotHumanIndividualInsulinInsulin-Dependent Diabetes MellitusInvestigationKnowledgeLeadLinkMapsMediatingModelingMolecularMolecular Mechanisms of ActionMutagenesisOpen Reading FramesOrgan SpecificityPathologyPatternPhenotypePhysiologicalPluripotent Stem CellsPopulationPredispositionPreventionProteinsProteomicsPublic HealthRegulator GenesRegulatory ElementReporterResearchSingle Nucleotide PolymorphismStructure of beta Cell of isletSystemTestingThymic epithelial cellThymus GlandTranscriptional RegulationTranslatingUntranslated RNAVariantabstractingautoreactive T cellbasecell typechromatin modificationchromosome conformation captureeffective therapyepigenomicsfunctional genomicsgene functiongenome wide association studyhuman stem cellshumanized mouseimprovedinnovationinsightnovelnovel strategiespreventrisk variantstem cell biologytooltranscription factortranscriptome sequencingtranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Abstract
Type 1 Diabetes (T1D) is an autoimmune disease in which the insulin-producing beta cells of the pancreas are
destroyed. These beta cells are specifically targeted for destruction by autoreactive T cells, which manage to
escape the normal elimination mechanisms in the thymus. Although it is clear that besides environmental
factors a strong genetic component is involved, the underlying basis for autoimmune T1D is not well
understood. GWAS for a number of diseases, including T1D, have recently highlighted regulatory DNA regions
rather than protein coding sequences as "hot spots" where single nucleotide polymorphisms (SNPs) as causal
variants can be found.
Our long term goal is to decipher the molecular mechanism of genotype-phenotype causalities in T1D. Our
overall objective is the in depth characterization of DNA regulatory elements and their risk variants that
underlie T1D susceptibility on a molecular and functional level.
Our central hypothesis is that T1D associated SNPs alter the function of cell type-specific DNA regulatory
elements. Guided by strong preliminary data, we will approach this hypothesis from 3 complementary angles:
We will use state-of-the-art and novel computational strategies to fine map T1D GWAS SNPs to candidate
causal variants (Aim 1). We will characterize the mechanism of action of causal candidates SNPs by utilizing a
combination of functional genomics and proteomics (Aim 2). Finally, we will determine the functional relevance
of causal variants in T1D-relevant human(-ized) systems (Aim 3).
This approach is highly innovative and will provide the first in depth functional characterization of DNA
regulatory elements and their risk variants that underlie T1D susceptibility. Our studies will provide a significant
shift from the correlative to the functional investigation of human T1D susceptibility. Ultimately, such knowledge
has the potential to translate to novel approaches to predict, prevent and potentially to treat T1D.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Proteogenomic Predictors of Recurrence in Non-small Cell Lung Cancer
-
批准号:10459716
-
项目类别:
-
资助金额:$108.43万
-
财政年份:2022
-
负责人:STEVEN A CARR
-
依托单位:
Center of Excellence for High Throughput Proteogenomic Characterization
-
批准号:10643840
-
项目类别:
-
资助金额:$106.63万
-
财政年份:2022
-
负责人:STEVEN A CARR
-
依托单位:
Proteogenomic Predictors of Recurrence in Non-small Cell Lung Cancer
-
批准号:10643902
-
项目类别:
-
资助金额:$103.23万
-
财政年份:2022
-
负责人:STEVEN A CARR
-
依托单位:
Center of Excellence for High Throughput Proteogenomic Characterization
-
批准号:10438235
-
项目类别:
-
资助金额:$108.81万
-
财政年份:2022
-
负责人:STEVEN A CARR
-
依托单位:
The 2019 Conference of the United States Human Proteome Organization (US HUPO)
-
批准号:9762425
-
项目类别:
-
资助金额:$1.3万
-
财政年份:2019
-
负责人:STEVEN A CARR
-
依托单位:
A Biochemical Roadmap of Exercise Signaling
-
批准号:9917974
-
项目类别:
-
资助金额:$143.03万
-
财政年份:2019
-
负责人:STEVEN A CARR
-
依托单位:
Mapping protein communication between organs in homeostasis and disease
-
批准号:10434875
-
项目类别:
-
资助金额:$163.86万
-
财政年份:2018
-
负责人:STEVEN A CARR
-
依托单位:
Mapping protein communication between organs in homeostasis and disease
-
批准号:10197922
-
项目类别:
-
资助金额:$164.21万
-
财政年份:2018
-
负责人:STEVEN A CARR
-
依托单位:
Mapping protein communication between organs in homeostasis and disease
-
批准号:9789868
-
项目类别:
-
资助金额:$164.88万
-
财政年份:2018
-
负责人:STEVEN A CARR
-
依托单位:
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS
-
批准号:9272692
-
项目类别:
-
资助金额:$145.25万
-
财政年份:2017
-
负责人:STEVEN A CARR
-
依托单位:
Proteomics
-
批准号:10491168
-
项目类别:
-
资助金额:$18.89万
-
财政年份:2016
-
负责人:STEVEN A CARR
-
依托单位:
Proteomics
-
批准号:10270043
-
项目类别:
-
资助金额:$19.67万
-
财政年份:2016
-
负责人:STEVEN A CARR
-
依托单位:
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
-
批准号:9301233
-
项目类别:
-
资助金额:$82.55万
-
财政年份:2016
-
负责人:STEVEN A CARR
-
依托单位:
A Biochemical Roadmap of Exercise Signaling
-
批准号:10460322
-
项目类别:
-
资助金额:$129.19万
-
财政年份:2016
-
负责人:STEVEN A CARR
-
依托单位:
Center of Excellence for High Throughput Proteogenomic Characterization
-
批准号:10001970
-
项目类别:
-
资助金额:$128.62万
-
财政年份:2016
-
负责人:STEVEN A CARR
-
依托单位:
A Biochemical Roadmap of Exercise Signaling
-
批准号:10318083
-
项目类别:
-
资助金额:$165.12万
-
财政年份:2016
-
负责人:STEVEN A CARR
-
依托单位:
Administrative Core
-
批准号:8597704
-
项目类别:
-
资助金额:$11.27万
-
财政年份:2013
-
负责人:STEVEN A CARR
-
依托单位:
Data Management and Resource Dissemination Core
-
批准号:8597713
-
项目类别:
-
资助金额:$13.02万
-
财政年份:2013
-
负责人:STEVEN A CARR
-
依托单位:
Technology Core: Proteomics
-
批准号:8597709
-
项目类别:
-
资助金额:$25.61万
-
财政年份:2013
-
负责人:STEVEN A CARR
-
依托单位:
The roles of biologically relevant ncRNAs
-
批准号:8597703
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2013
-
负责人:STEVEN A CARR
-
依托单位:
海外基金